Form 4: CalciMedica Director Robert N. Wilson Acquires 51,278 Shares

Director Robert N. Wilson of CalciMedica, Inc. purchased 51,278 shares of common stock at an average price of $3.52 on June 28, 2024.

Summary

• On June 28, 2024, Robert N. Wilson, a director of CalciMedica, Inc., acquired 51,278 shares of common stock.
• The purchase was made at a weighted average price of $3.52 per share.
• The price range for the shares purchased was between $3.2997 and $3.7935.
• Following the transaction, Wilson directly owns 310,196 shares of CalciMedica common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but without more context, it's difficult to assess the significance.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This allows investors to monitor the actions of those with the most knowledge of the company.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive sign of confidence in the company's prospects.

Key Dates